HRT FINANCIAL LP

Position in ARGX — Argenx SE

CIK 1475597 NEW YORK, NY

Position in ARGX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$13,695,108

-$2,858,151 QoQ

Shares Held

18,754

-4.7% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $416,760,191 across 198 Biotechnology names. ARGX ranks #6 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	128,633	$42,560,800
2	IBRX	ImmunityBio, Inc.	3,925,446	$30,108,170
3	EXEL	Exelixis, Inc.	460,585	$19,754,490
4	IONS	Ionis Pharmaceuticals Inc	252,250	$18,941,452
5	MRNA	Moderna, Inc.	368,421	$18,715,786
6	ARGX	Argenx SE This page	18,754	$13,695,108
7	RARE	Ultragenyx Pharmaceutical Inc.	613,229	$12,847,147
8	IOVA	Iovance Biotherapeutics, Inc.	3,486,299	$12,236,909

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,695,108	18,754	-4.7%	Shares	Defined	2026-05-14
2025-12-31	$16,553,259	19,684	+120.3%	Shares	Defined	2026-02-12
2025-09-30	$6,590,098	8,935	+183.9%	Shares	Defined	2025-11-14
2025-06-30	$1,734,689	3,147	-69.3%	Shares	Defined	2025-08-14
2025-03-31	$6,076,677	10,267	-7.7%	Shares	Defined	2025-05-15
2024-12-31	$6,838,800	11,120	+376.4%	Shares	Defined	2025-02-14
2024-06-30	$1,003,713	2,334	+50.6%	Shares	Defined	2024-08-12
2021-12-31	$542,794	1,550	+96.2%	Shares	Defined	2022-02-14
2021-03-31	$217,558	790	-12.4%	Shares	Defined	2021-05-17
2020-06-30	$203,157	902	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.